RU94043769A - Способ повышения продукции протеина с, способ повышения уровня его модификации - Google Patents

Способ повышения продукции протеина с, способ повышения уровня его модификации

Info

Publication number
RU94043769A
RU94043769A RU94043769/13A RU94043769A RU94043769A RU 94043769 A RU94043769 A RU 94043769A RU 94043769/13 A RU94043769/13 A RU 94043769/13A RU 94043769 A RU94043769 A RU 94043769A RU 94043769 A RU94043769 A RU 94043769A
Authority
RU
Russia
Prior art keywords
increase
protein
recombinant proteins
production
functional
Prior art date
Application number
RU94043769/13A
Other languages
English (en)
Other versions
RU2110574C1 (ru
Inventor
Уилльям Гриннелл Брайен
Us]
Original Assignee
Эли Лилли энд Компани (US)
Эли Лилли Энд Компани
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Эли Лилли энд Компани (US), Эли Лилли Энд Компани filed Critical Эли Лилли энд Компани (US)
Publication of RU94043769A publication Critical patent/RU94043769A/ru
Application granted granted Critical
Publication of RU2110574C1 publication Critical patent/RU2110574C1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6464—Protein C (3.4.21.69)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21069—Protein C activated (3.4.21.69)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/02—Cells for production
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2523/00—Culture process characterised by temperature

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Изобретение относится к способу продуцирования высоких уровней функциональных рекомбинантных протеинов в аденовирус-трансформированных клетках млекопитающих путем инкубирования клеток, способных к продуцированию рекомбинантных протеинов, при температуре, колеблющейся между 38 - 39C. Способ дает более высокие уровни экспрессии общего протеина в некоторых клеточных линиях и более высокие уровни функционального протеина в остальных клеточных линиях.

Claims (1)

  1. Изобретение относится к способу продуцирования высоких уровней функциональных рекомбинантных протеинов в аденовирус-трансформированных клетках млекопитающих путем инкубирования клеток, способных к продуцированию рекомбинантных протеинов, при температуре, колеблющейся между 38 - 39oC. Способ дает более высокие уровни экспрессии общего протеина в некоторых клеточных линиях и более высокие уровни функционального протеина в остальных клеточных линиях.
RU94043769A 1993-12-15 1994-12-14 Способ повышения продукции протеина с (варианты) RU2110574C1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/168,035 US5618714A (en) 1993-12-15 1993-12-15 Methods for producing protein C
US08/168,035 1993-12-15

Publications (2)

Publication Number Publication Date
RU94043769A true RU94043769A (ru) 1997-03-27
RU2110574C1 RU2110574C1 (ru) 1998-05-10

Family

ID=22609820

Family Applications (1)

Application Number Title Priority Date Filing Date
RU94043769A RU2110574C1 (ru) 1993-12-15 1994-12-14 Способ повышения продукции протеина с (варианты)

Country Status (28)

Country Link
US (1) US5618714A (ru)
EP (1) EP0658626B1 (ru)
JP (1) JP3662614B2 (ru)
KR (1) KR950018454A (ru)
CN (1) CN1107887A (ru)
AT (1) ATE196165T1 (ru)
AU (1) AU687914B2 (ru)
BR (1) BR9404991A (ru)
CA (1) CA2138101A1 (ru)
CO (1) CO4340654A1 (ru)
CZ (2) CZ315794A3 (ru)
DE (1) DE69425809T2 (ru)
DK (1) DK0658626T3 (ru)
ES (1) ES2149244T3 (ru)
FI (1) FI106385B (ru)
GR (1) GR3034909T3 (ru)
HU (1) HU219508B (ru)
IL (1) IL111983A0 (ru)
NO (1) NO944846L (ru)
NZ (1) NZ270140A (ru)
PE (1) PE42695A1 (ru)
PL (1) PL176381B1 (ru)
PT (1) PT658626E (ru)
RU (1) RU2110574C1 (ru)
SI (1) SI0658626T1 (ru)
UA (1) UA26870C2 (ru)
YU (1) YU73494A (ru)
ZA (1) ZA949981B (ru)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19724543A1 (de) * 1997-06-11 1998-12-17 Philips Patentverwaltung Wechsler-Gerät für Informationsplatten
HUP0303199A2 (hu) 2001-02-19 2003-12-29 Merck Patent Gmbh Eljárás T-sejt-epitópok azonosítására és csökkentett immunogenitású molekulák előállítására
ATE386824T1 (de) * 2002-03-29 2008-03-15 Merck & Co Inc Verfahren zur virusproduktion
US20070142272A1 (en) * 2003-01-24 2007-06-21 Zlokovic Berislav V Neuroprotective activity of activated protein c independent of its anticoagulant activity
WO2006014839A2 (en) * 2004-07-23 2006-02-09 The University Of Rochester Activated protein c inhibits undesirable effects of plasminogen activator in the brain
EP1913155A4 (en) * 2005-06-23 2009-08-12 Univ British Columbia COAGULATION FACTOR III POLYMORPHISMS ASSOCIATED WITH PREDICTION RELATING TO THE RESULTS AND RESPONSE OF A SUBJECT TO THERAPY
CA2654761A1 (en) * 2006-06-09 2007-12-13 The University Of British Columbia Interferon gamma polymorphisms as indicators of subject outcome in critically ill subjects
US20110171200A1 (en) * 2008-01-15 2011-07-14 Walley Keith R Protein c rs2069915 as a response predictor to survival and administration of activated protein c or protein c-like compound
WO2012068519A2 (en) 2010-11-19 2012-05-24 Sirius Genomics Inc. Markers associated with response to activated protein c administration, and uses thereof

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4775624A (en) * 1985-02-08 1988-10-04 Eli Lilly And Company Vectors and compounds for expression of human protein C
US4959318A (en) * 1985-06-27 1990-09-25 Zymogenetics, Inc. Expression of protein C
US4968626A (en) * 1985-08-15 1990-11-06 Board Of Reagents Of The University Of Washington DNA sequence coding for protein C
EP0245949B1 (en) * 1986-04-09 1997-10-29 Eli Lilly And Company A method of using eukaryotic expression vectors comprising the bk virus enhancer
JPH01502080A (ja) * 1986-11-17 1989-07-27 ニュー・イングランド・メディカル・センター 組み換えビタミンｋ依存性蛋白質のガンマカルボキシル化の増強
US4992373A (en) * 1987-12-04 1991-02-12 Eli Lilly And Company Vectors and compounds for direct expression of activated human protein C
ZA889497B (en) * 1987-12-28 1990-08-29 Lilly Co Eli Vectors and compounds for expression of zymogen forms of human protein c
JPH0246296A (ja) * 1988-08-09 1990-02-15 Hoechst Japan Ltd 雑種プロテインｃ及びその製造方法
US4981952A (en) * 1988-10-04 1991-01-01 Eli Lilly And Company Method for the purification of vitamin K-dependent proteins
CA1332049C (en) * 1988-10-07 1994-09-20 Eli Lilly And Company Eukaryotic expression
ATE97958T1 (de) * 1989-08-11 1993-12-15 Zymogenetics Inc Zellenzuchtverfahren fuer die produktion von aktiviertem protein-c.
IL97312A (en) * 1990-02-23 1999-01-26 Lilly Co Eli A method of generating a polypeptide in an eukaryotic vector AND recombinant surrogate cell containing an enhanced transcriptional control unit based on the primary late adenovirus coefficient
AU1180692A (en) * 1991-01-29 1992-08-27 Teijin Limited Human protein c expression vector

Also Published As

Publication number Publication date
HUT69979A (en) 1995-09-28
NO944846L (no) 1995-06-16
ATE196165T1 (de) 2000-09-15
CA2138101A1 (en) 1995-06-16
PL176381B1 (pl) 1999-05-31
DE69425809D1 (de) 2000-10-12
JP3662614B2 (ja) 2005-06-22
YU73494A (sh) 1997-03-07
BR9404991A (pt) 1995-08-08
PT658626E (pt) 2001-01-31
DE69425809T2 (de) 2001-02-01
PE42695A1 (es) 1995-12-12
EP0658626B1 (en) 2000-09-06
SI0658626T1 (en) 2001-02-28
NO944846D0 (no) 1994-12-14
DK0658626T3 (da) 2000-10-16
US5618714A (en) 1997-04-08
CZ290724B6 (cs) 2002-10-16
CO4340654A1 (es) 1996-07-30
ZA949981B (en) 1996-06-14
EP0658626A1 (en) 1995-06-21
IL111983A0 (en) 1995-03-15
AU8045294A (en) 1995-06-22
ES2149244T3 (es) 2000-11-01
JPH07222589A (ja) 1995-08-22
HU9403600D0 (en) 1995-02-28
CN1107887A (zh) 1995-09-06
UA26870C2 (ru) 1999-12-29
FI945877A (fi) 1995-06-16
FI106385B (fi) 2001-01-31
CZ315794A3 (en) 1995-10-18
AU687914B2 (en) 1998-03-05
RU2110574C1 (ru) 1998-05-10
GR3034909T3 (en) 2001-02-28
HU219508B (hu) 2001-04-28
PL306291A1 (en) 1995-06-26
FI945877A0 (fi) 1994-12-14
KR950018454A (ko) 1995-07-22
NZ270140A (en) 1996-05-28

Similar Documents

Publication Publication Date Title
ES8202362A1 (es) Procedimiento para preparar un acido desoxi-ribonucleico (adn) recombinante
CA2080920A1 (en) Cloning by complementation and related processes
DK0749444T3 (da) Human/dyre-faktor VIII-hybrid
BRPI0516572A (pt) métodos e composições para melhorar a produção de proteìnas recombinantes
WO2002101019A3 (en) Methods of culturing animal cells and polypeptide production in animal cells
AU7945682A (en) Rennin from recombinant dna
MY125594A (en) Immortalized cell lines for virus growth
AR020735A1 (es) Un procedimiento para la obtencion de un polipeptido glucosilado a partir de celulas eucarioticas
NO970514D0 (no) Bakteriell produksjon av hydrofobiske polypeptider
WO2004090096A3 (en) Methods for neural differentiation of embryonic stem cells using protease passaging techniques
RU94043769A (ru) Способ повышения продукции протеина с, способ повышения уровня его модификации
DE60138127D1 (de) Stoffwechseländerungen in gärungen zur produktion rekombinanter proteine
DE69033961D1 (de) Zellinien, die einen biologisch aktiven faktor-ix exprimieren
ATE302282T1 (de) Erhöhte herstellung von sekretierten proteinen durch rekombinante hefezellen
ATE205538T1 (de) Genregulatorische sequenzen von cd4, welche spezifisch in reifen t-zellen exprimiert werden
ATE293170T1 (de) Phage-abhängige superproduktion von biologisch aktiven proteinen und peptiden
ATE288476T1 (de) Herstellung von proteinen
ATE97958T1 (de) Zellenzuchtverfahren fuer die produktion von aktiviertem protein-c.
Venezky et al. European Science Notes. Volume 40, Number 3.
MX9603037A (es) Materiales y metodos para manejar rechazo hiperagudo en xenotrasplante humano.
KR890006816A (ko) 배양 동물 세포 내에서 단백질 생산을 증가시키기 위한 유전자 증폭 방법